Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Paris - Delayed Quote EUR

Boiron SA (BOI.PA)

Compare
24.35
-0.80
(-3.16%)
As of 9:00:25 AM GMT+2. Market Open.
Loading Chart for BOI.PA
  • Previous Close 25.15
  • Open 24.50
  • Bid --
  • Ask --
  • Day's Range 24.35 - 24.50
  • 52 Week Range 22.90 - 36.35
  • Volume 487
  • Avg. Volume 3,194
  • Market Cap (intraday) 422.772M
  • Beta (5Y Monthly) 0.34
  • PE Ratio (TTM) 17.90
  • EPS (TTM) 1.36
  • Earnings Date Apr 3, 2025
  • Forward Dividend & Yield 1.35 (5.37%)
  • Ex-Dividend Date Jun 3, 2024
  • 1y Target Est 27.00

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

www.boiron.fr

2,788

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BOI.PA

View More

Performance Overview: BOI.PA

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .

YTD Return

BOI.PA
9.14%
CAC 40 (^FCHI)
2.07%

1-Year Return

BOI.PA
28.33%
CAC 40 (^FCHI)
7.58%

3-Year Return

BOI.PA
11.41%
CAC 40 (^FCHI)
11.91%

5-Year Return

BOI.PA
26.65%
CAC 40 (^FCHI)
81.32%

Compare To: BOI.PA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BOI.PA

View More

Valuation Measures

Annual
As of 4/3/2025
  • Market Cap

    436.66M

  • Enterprise Value

    398.18M

  • Trailing P/E

    18.49

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.91

  • Price/Book (mrq)

    1.17

  • Enterprise Value/Revenue

    0.83

  • Enterprise Value/EBITDA

    7.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.92%

  • Return on Assets (ttm)

    4.41%

  • Return on Equity (ttm)

    4.85%

  • Revenue (ttm)

    481.71M

  • Net Income Avi to Common (ttm)

    23.69M

  • Diluted EPS (ttm)

    1.36

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    53.33M

  • Total Debt/Equity (mrq)

    3.98%

  • Levered Free Cash Flow (ttm)

    28.62M

Research Analysis: BOI.PA

View More

Company Insights: BOI.PA

Research Reports: BOI.PA

View More

People Also Watch